This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.
The price of Gruma SAB de CV Sponsored ADR Class B () is up 48.7% since the first of the year. Gruma S.A.B. de C.V. produces and markets corn flour, wheat flour, and tortillas. .
Since January 1, Shanda Games Ltd. Sponsored ADR Class A () has shot up 52.3%. Shanda Games develops, sources and operates Internet games in China. The stock’s trailing PE Ratio is 7.60. .
Since the first of the year, shares of Delta Air Lines, Inc. () have soared 52.9%. Delta Air Lines operates as an airline for passengers and cargo traveling throughout the United States and around the world. The stock currently has a trailing PE Ratio of 3.30. .
Since the first of the year, the price of Green Plains Inc. () has swelled 60.1%. Green Plains Renewable Energy constructs and operates dry mill, fuel-grade ethanol production facilities. .
Since January 1, EQT Midstream Partners LP () has jumped 60.4%. EQT Midstream Partners provides natural gas transmission, storage, and gathering services in Pennsylvania and West Virginia. .
Shares of Repligen Corporation () have leaped 60.6% since January 1. Repligen is a biopharmaceutical company that develops therapeutics for radiology and neuropsychiatry. .
Since January 1, the price of Illumina, Inc. () has grown 61.1%. Illumina develops, manufactures and markets integrated systems for the large-scale analysis of genetic variation and biological function. .
Shares of Forest Laboratories, Inc. () have risen 64.4% since January 1. Forest Laboratories develops, manufactures, and sells both branded and generic forms of ethical products which require a physician’s prescription. .
Since January 1, Texas Pacific Land () has climbed 65.1%. Texas Pacific Land Trust derives revenue from all avenues of managing land, such as royalties from oil and gas and land sales. .
The price of Questcor Pharmaceuticals, Inc. () has seen a 65.5% boost since the first of the year. Questcor Pharmaceuticals develops and commercializes novel central nervous system-focused therapeutics that address significant unmet medical needs. .
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
No comments:
Post a Comment